Advertisement

Topics

Merck Fellowship for Global Health and PNRI partner to advance promising antifungal

20:00 EDT 7 Aug 2017 | AAAS

(Pacific Northwest Research Institute) The Pacific Northwest Research Institute is partnering with three Fellows from the Merck Fellowship for Global Health program to create a comprehensive plan to move a promising antifungal agent from the laboratory to clinical practice. The compound has the potential to reduce the burden of opportunistic infections in people living with HIV in developing countries. PNRI is one of only ten organizations worldwide selected to participate in Merck's prestigious program this year.

Original Article: Merck Fellowship for Global Health and PNRI partner to advance promising antifungal

NEXT ARTICLE

More From BioPortfolio on "Merck Fellowship for Global Health and PNRI partner to advance promising antifungal"

Quick Search
Advertisement
 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...